A Phase 1b Extension Trial To Allow Repeat Intracerebroventricular Injections of Ex Vivo Expanded, Autologous Adipose-Derived Stem Cells (RB-ADSCs) in Subjects Previously Treated in RBI Protocol RB-ADSC-02
Latest Information Update: 04 Feb 2026
At a glance
- Drugs Autologous stem cell therapy (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors Regeneration Biomedical
Most Recent Events
- 04 Feb 2026 New trial record